Skip to main content
Gut logoLink to Gut
. 1983 Mar;24(3):177–181. doi: 10.1136/gut.24.3.177

Toward optimal use of corticosteroids in ulcerative colitis and Crohn's disease.

J E Lennard-Jones
PMCID: PMC1419936  PMID: 6337933

Full text

PDF
177

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Al-Habet S., Rogers H. J. Pharmacokinetics of intravenous and oral prednisolone. Br J Clin Pharmacol. 1980 Nov;10(5):503–508. doi: 10.1111/j.1365-2125.1980.tb01796.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. BARON J. H., CONNELL A. M., KANAGHINIS T. G., LENNARD-JONES J. E., JONES A. F. Out-patient treatment of ulcerative colitis. Comparison between three doses of oral prednisone. Br Med J. 1962 Aug 18;2(5302):441–443. doi: 10.1136/bmj.2.5302.441. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bakran I., Jr, Korsić M., Duraković Z., Vrhovac B., Tajić M. The effect of alternate-day prednisone therapy on cortisol secretion rate in corticosteroid-dependent asthmatics. Int J Clin Pharmacol Biopharm. 1977 Feb;15(2):57–60. [PubMed] [Google Scholar]
  4. Batt R. M., Scott J. Response of the small intestinal mucosa to oral glucocorticoids. Scand J Gastroenterol Suppl. 1982;74:75–88. [PubMed] [Google Scholar]
  5. Berghouse L. M., Elliott P. R., Lennard-Jones J. E., English J., Marks V. Plasma prednisolone levels during intravenous therapy in acute colitis. Gut. 1982 Nov;23(11):980–983. doi: 10.1136/gut.23.11.980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bergman L., Krause U. Postoperative treatment with corticosteroids and salazosulphapyridine (Salazopyrin) after radical resection for Crohn's disease. Scand J Gastroenterol. 1976;11(7):651–656. [PubMed] [Google Scholar]
  7. Elliott P. R., Powell-Tuck J., Gillespie P. E., Laidlow J. M., Lennard-Jones J. E., English J., Chakraborty J., Marks V. Prednisolone absorption in acute colitis. Gut. 1980 Jan;21(1):49–51. doi: 10.1136/gut.21.1.49. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Friedman M., Hinton J. M., Lennard-Jones J. E. Adrenal and clinical responses to corticotrophin and prednisone in inflammatory disease of the colon. Gut. 1969 Mar;10(3):194–197. doi: 10.1136/gut.10.3.194. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hawkey C. J., Truelove S. C. Effect of prednisolone on prostaglandin synthesis by rectal mucosa in ulcerative colitis: investigation by laminar flow bioassay and radioimmunoassay. Gut. 1981 Mar;22(3):190–193. doi: 10.1136/gut.22.3.190. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Kaplan H. P., Portnoy B., Binder H. J., Amatruda T., Spiro H. A controlled evaluation of intravenous adrenocorticotropic hormone and hydrocortisone in the treatment of acute colitis. Gastroenterology. 1975 Jul;69(1):91–95. [PubMed] [Google Scholar]
  11. Kirk A. P., Lennard-Jones J. E. Controlled trial of azathioprine in chronic ulcerative colitis. Br Med J (Clin Res Ed) 1982 May 1;284(6325):1291–1292. doi: 10.1136/bmj.284.6325.1291. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Kumana C. R., Seaton T., Meghji M., Castelli M., Benson R., Sivakumaran T. Beclomethasone dipropionate enemas for treating inflammatory bowel disease without producing Cushing's syndrome or hypothalamic pituitary adrenal suppression. Lancet. 1982 Mar 13;1(8272):579–583. doi: 10.1016/s0140-6736(82)91747-0. [DOI] [PubMed] [Google Scholar]
  13. LENNARD-JONES J. E., MISIEWICZ J. J., CONNELL A. M., BARON J. H., JONES F. A. PREDNISONE AS MAINTENANCE TREATMENT FOR ULCERATIVE COLITIS IN REMISSION. Lancet. 1965 Jan 23;1(7378):188–189. doi: 10.1016/s0140-6736(65)90973-6. [DOI] [PubMed] [Google Scholar]
  14. Lee D. A., Taylor M., James V. H., Walker G. Rectally administered prednisolone--evidence for a predominantly local action. Gut. 1980 Mar;21(3):215–218. doi: 10.1136/gut.21.3.215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Lennard-Jones J. E. Azathioprine and 6-mercaptopurine have a role in the treatment of Crohn's disease. Dig Dis Sci. 1981 Apr;26(4):364–368. doi: 10.1007/BF01308381. [DOI] [PubMed] [Google Scholar]
  16. Lewis G. P., Jusko W. J., Graves L., Burke C. W. Prednisone side-effects and serum-protein levels. A collaborative study. Lancet. 1971 Oct 9;2(7728):778–780. doi: 10.1016/s0140-6736(71)92738-3. [DOI] [PubMed] [Google Scholar]
  17. Pickup M. E. Clinical pharmacokinetics of prednisone and prednisolone. Clin Pharmacokinet. 1979 Mar-Apr;4(2):111–128. doi: 10.2165/00003088-197904020-00004. [DOI] [PubMed] [Google Scholar]
  18. Powell-Tuck J., Bown R. L., Chambers T. J., Lennard-Jones J. E. A controlled trial of alternate day prednisolone as a maintenance treatment for ulcerative colitis in remission. Digestion. 1981;22(5):263–270. doi: 10.1159/000198667. [DOI] [PubMed] [Google Scholar]
  19. Powell-Tuck J., Bown R. L., Lennard-Jones J. E. A comparison of oral prednisolone given as single or multiple daily doses for active proctocolitis. Scand J Gastroenterol. 1978;13(7):833–837. doi: 10.3109/00365527809182199. [DOI] [PubMed] [Google Scholar]
  20. Powell-Tuck J., Buckell N. A., Lennard-Jones J. E. A controlled comparison of corticotropin and hydrocortisone in the treatment of severe proctocolitis. Scand J Gastroenterol. 1977;12(8):971–975. doi: 10.3109/00365527709181359. [DOI] [PubMed] [Google Scholar]
  21. Shaffer J. A., Williams S. E., Turnberg L. A., Houston J. B., Rowland M. Absorption of prednisolone in patients with Crohn's disease. Gut. 1983 Mar;24(3):182–186. doi: 10.1136/gut.24.3.182. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Summers R. W., Switz D. M., Sessions J. T., Jr, Becktel J. M., Best W. R., Kern F., Jr, Singleton J. W. National Cooperative Crohn's Disease Study: results of drug treatment. Gastroenterology. 1979 Oct;77(4 Pt 2):847–869. [PubMed] [Google Scholar]
  23. Swartz S. L., Dluhy R. G. Corticosteroids: clinical pharmacology and therapeutic use. Drugs. 1978 Sep;16(3):238–255. doi: 10.2165/00003495-197816030-00006. [DOI] [PubMed] [Google Scholar]
  24. TRUELOVE S. C., WITTS L. J. Cortisone in ulcerative colitis; final report on a therapeutic trial. Br Med J. 1955 Oct 29;2(4947):1041–1048. doi: 10.1136/bmj.2.4947.1041. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Tanner A. R., Halliday J. W., Powell L. W. Serum prednisolone levels in Crohn's disease and coeliac disease following oral prednisolone administration. Digestion. 1981;21(6):310–315. doi: 10.1159/000198583. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES